The hormone binding domain (HBD) of the glucocorticoid receptor (GR) contains five cysteine residues, with three of them being spaced close to one another in the steroid binding pocket. The HBD also contains the contact region for the chaperone protein hsp90, which must be bound to the GR for it to have a steroid binding conformation. Binding of hsp90 to the receptor through its HBD inactivates the DNA binding domain (DBD). The DBD contains a number of cysteines essential to its DNA binding activity. Here, we assess the effects of hsp90 binding on the accessibility of cysteine residues in both the HBD and DBD to derivatization by a thiol-specific reagent. We report that N-iodoacetyltyrosine (IAT) inactivates steroid binding activity of the immunopurified, untransformed GRhsp90 complex in a manner that is prevented by the sulfhydryl reagents cysteine and dithiothreitol but is not reversed by them. The I-labeled IAT derivative N-iodoacetyl-3-[I]iodotyrosine ([I]IAIT) covalently labels the immunopurified, hsp90-bound receptor in a thiol-specific manner. Dissociation of hsp90 leads to an 2-fold increase in [I]IAIT labeling of the full-length, 100-kDa GR. The increase in thiol labeling is related to the presence of hsp90 because it is blocked by molybdate, which prevents hsp90 dissociation. Cleavage of the [I]IAIT-labeled receptor with trypsin yields a 15-kDa labeled fragment containing the DBD and a 30-kDa labeled fragment containing all of the cysteines in the HBD and the contact region for hsp90. Dissociation of hsp90 from the GR results in a 2.3-fold increase in [I]IAIT labeling of the 15-kDa fragment and a 50% decrease in labeling of the 30-kDa fragment. These data are consistent with the proposal that dissociation of hsp90 from the GR produces a conformational change in the HBD such that some of the thiols that are exposed in the GRhsp90 complex become buried and are no longer accessible to the [I]IAIT probe. In contrast, binding of the GR to hsp90 restricts access of cysteines in the DBD to this small thiol-derivatizing agent, a restriction that is relieved as a result of unmasking or conformational change accompanying hsp90 dissociation.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. S. Billecke, D. I. Draganov, Y. Morishima, P. J. M. Murphy, A. Y. Dunbar, W. B. Pratt, and Y. Osawa The Role of hsp90 in Heme-dependent Activation of Apo-neuronal Nitric-oxide Synthase J. Biol. Chem., July 16, 2004; 279(29): 30252 - 30258. [Abstract] [Full Text] [PDF]

				M. C. Rosenhagen, C. Soti, U. Schmidt, G. M. Wochnik, F. U. Hartl, F. Holsboer, J. C. Young, and T. Rein The Heat Shock Protein 90-Targeting Drug Cisplatin Selectively Inhibits Steroid Receptor Activation Mol. Endocrinol., October 1, 2003; 17(10): 1991 - 2001. [Abstract] [Full Text] [PDF]

				P. J. M. Murphy, Y. Morishima, H. Chen, M. D. Galigniana, J. F. Mansfield, S. S. Simons Jr., and W. B. Pratt Visualization and Mechanism of Assembly of a Glucocorticoid Receptor{middle dot}Hsp70 Complex That Is Primed for Subsequent Hsp90-dependent Opening of the Steroid Binding Cleft J. Biol. Chem., September 12, 2003; 278(37): 34764 - 34773. [Abstract] [Full Text] [PDF]

				Y. Osawa, E. R. Lowe, A. C. Everett, A. Y. Dunbar, and S. S. Billecke Proteolytic Degradation of Nitric Oxide Synthase: Effect of Inhibitors and Role of hsp90-Based Chaperones J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 493 - 497. [Abstract] [Full Text] [PDF]

				W. B. Pratt and D. O. Toft Regulation of Signaling Protein Function and Trafficking by the hsp90/hsp70-Based Chaperone Machinery Experimental Biology and Medicine, February 1, 2003; 228(2): 111 - 133. [Abstract] [Full Text] [PDF]

				S. Kaul, P. J. M. Murphy, J. Chen, L. Brown, W. B. Pratt, and S. S. Simons Jr. Mutations at Positions 547-553 of Rat Glucocorticoid Receptors Reveal That hsp90 Binding Requires the Presence, but Not Defined Composition, of a Seven-amino Acid Sequence at the Amino Terminus of the Ligand Binding Domain J. Biol. Chem., September 20, 2002; 277(39): 36223 - 36232. [Abstract] [Full Text] [PDF]

				K. C. Kanelakis, D. S. Shewach, and W. B. Pratt Nucleotide Binding States of hsp70 and hsp90 during Sequential Steps in the Process of Glucocorticoid Receptor{middle dot}hsp90 Heterocomplex Assembly J. Biol. Chem., September 6, 2002; 277(37): 33698 - 33703. [Abstract] [Full Text] [PDF]

				S. S. Billecke, A. T. Bender, K. C. Kanelakis, P. J. M. Murphy, E. R. Lowe, Y. Kamada, W. B. Pratt, and Y. Osawa hsp90 Is Required for Heme Binding and Activation of Apo-Neuronal Nitric-oxide Synthase. GELDANAMYCIN-MEDIATED OXIDANT GENERATION IS UNRELATED TO ANY ACTION OF hsp90 J. Biol. Chem., May 31, 2002; 277(23): 20504 - 20509. [Abstract] [Full Text] [PDF]

				Y. Morishima, K. C. Kanelakis, A. M. Silverstein, K. D. Dittmar, L. Estrada, and W. B. Pratt The Hsp Organizer Protein Hop Enhances the Rate of but Is Not Essential for Glucocorticoid Receptor Folding by the Multiprotein Hsp90-based Chaperone System J. Biol. Chem., March 15, 2000; 275(10): 6894 - 6900. [Abstract] [Full Text] [PDF]

				G. Giannoukos, A. M. Silverstein, W. B. Pratt, and S. S. Simons Jr. The Seven Amino Acids (547-553) of Rat Glucocorticoid Receptor Required for Steroid and Hsp90 Binding Contain a Functionally Independent LXXLL Motif That Is Critical for Steroid Binding J. Biol. Chem., December 17, 1999; 274(51): 36527 - 36536. [Abstract] [Full Text] [PDF]

				M. D. Galigniana, G. Piwien-Pilipuk, and J. Assreuy Inhibition of Glucocorticoid Receptor Binding by Nitric Oxide Mol. Pharmacol., February 1, 1999; 55(2): 317 - 323. [Abstract] [Full Text]

				A. T. Bender, A. M. Silverstein, D. R. Demady, K. C. Kanelakis, S. Noguchi, W. B. Pratt, and Y. Osawa Neuronal Nitric-oxide Synthase Is Regulated by the hsp90-based Chaperone System in Vivo J. Biol. Chem., January 15, 1999; 274(3): 1472 - 1478. [Abstract] [Full Text] [PDF]

				M. Xu, K. D. Dittmar, G. Giannoukos, W. B. Pratt, and S. S. Simons Jr. Binding of hsp90 to the Glucocorticoid Receptor Requires a Specific 7-Amino Acid Sequence at the Amino Terminus of the Hormone-binding Domain J. Biol. Chem., May 29, 1998; 273(22): 13918 - 13924. [Abstract] [Full Text] [PDF]

				K. D. Dittmar, D. R. Demady, L. F. Stancato, P. Krishna, and W. B. Pratt Folding of the Glucocorticoid Receptor by the Heat Shock Protein (hsp) 90-based Chaperone Machinery. THE ROLE OF p23 IS TO STABILIZE RECEPTOR·hsp90 HETEROCOMPLEXES FORMED BY hsp90·p60·hsp70 J. Biol. Chem., August 22, 1997; 272(34): 21213 - 21220. [Abstract] [Full Text] [PDF]

				W. B. Pratt and D. O. Toft Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones Endocr. Rev., June 1, 1997; 18(3): 306 - 360. [Abstract] [Full Text]

				K. D. Dittmar and W. B. Pratt Folding of the Glucocorticoid Receptor by the Reconstituted hsp90-based Chaperone Machinery. THE INITIAL hsp90·p60·hsp70-DEPENDENT STEP IS SUFFICIENT FOR CREATING THE STEROID BINDING CONFORMATION J. Biol. Chem., May 16, 1997; 272(20): 13047 - 13054. [Abstract] [Full Text] [PDF]

				Y. Morishima, P. J. M. Murphy, D.-P. Li, E. R. Sanchez, and W. B. Pratt Stepwise Assembly of a Glucocorticoid Receptor{middle dot}hsp90 Heterocomplex Resolves Two Sequential ATP-dependent Events Involving First hsp70 and Then hsp90 in Opening of the Steroid Binding Pocket J. Biol. Chem., June 9, 2000; 275(24): 18054 - 18060. [Abstract] [Full Text] [PDF]

				P. J. M. Murphy, K. C. Kanelakis, M. D. Galigniana, Y. Morishima, and W. B. Pratt Stoichiometry, Abundance, and Functional Significance of the hsp90/hsp70-based Multiprotein Chaperone Machinery in Reticulocyte Lysate J. Biol. Chem., August 3, 2001; 276(32): 30092 - 30098. [Abstract] [Full Text] [PDF]